SH3GL2 and laryngeal carcinoma: Consistent with this possibility, analyses in head and neck squamous cell carcinoma, breast carcinoma, laryngeal carcinoma and urothelial carcinoma have implicated SH3GL2 as a candidate tumor suppressor [18], [33], [34], [35].